GGHC
WST icon

Gilder Gagnon Howe & Co’s West Pharmaceutical WST Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-19,060
Closed -$840K – 322
2014
Q1 		$840K Buy
19,060
+1,949
+11% +$91.7K 0.01% 214
2013
Q4 		$839K Buy
+17,111
New +$801K 0.01% 212

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Gilder Gagnon Howe & Co's WST Position: Q2 2014 in Review

Gilder Gagnon Howe & Co sold out of West Pharmaceutical (WST) in Q2 2014, closing a stake of 19,060 shares — an estimated $840K sold.

Gilder Gagnon Howe & Co first reported a position in WST in Q4 2013 and held it in 2 quarters. The position peaked at $840K in Q1 2014. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

  • Gilder Gagnon Howe & Co reported no remaining West Pharmaceutical position as of Q2 2014 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 19,060 West Pharmaceutical shares in Q2 2014, an estimated $840K.
  • Gilder Gagnon Howe & Co first reported a position in West Pharmaceutical in Q4 2013 and held it in 2 quarters.
  • Gilder Gagnon Howe & Co's West Pharmaceutical position peaked at $840K in Q1 2014.
  • 222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2014, filed 1 Aug 2014.